- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
AFG3L2 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP13219a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP13219a-ev20 | Ev20 size 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
AFG3L2 Antibody (N-term) - Product info | |
| Application | WB, IHC
|
| Primary Accession | Q9Y4W6 |
| Other Accession | Q8JZQ2, Q2KJI7, NP_006787.2 |
| Reactivity | Human |
| Predicted | Bovine, Mouse |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 88584 Da |
AFG3L2 Antibody (N-term) - Additional info | |
| Gene ID 10939 | |
| Other Names AFG3L2; AFG3-like protein 2; Paraplegin-like protein | |
| Target/Specificity This AFG3L2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 51-80 amino acids from the N-terminal region of human AFG3L2. | |
| Dilution WB~~1:100~500WB~~1:1000 IHC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions AFG3L2 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
AFG3L2 Antibody (N-term) - Protein Information | |
| Name AFG3L2 | |
| Function ATP-dependent protease which is essential for axonal development (By similarity) | |
| Cellular Location Mitochondrion membrane; Multi-pass membrane protein | |
| Tissue Location Ubiquitous. Highly expressed in the cerebellar Purkinje cells | |
AFG3L2 Antibody (N-term) - Related products
AFG3L2 Antibody (N-term) - Application data
-
AFG3L2 Antibody (N-term) (Cat. #AP13219a) western blot analysis in MDA-MB453,MCF-7,Jurkat cell line lysates (35ug/lane).This demonstrates the AFG3L2 antibody detected the AFG3L2 protein (arrow).
-
AFG3L2 Antibody (N-term) (Cat. #AP13219a)immunohistochemistry analysis in formalin fixed and paraffin embedded human cerebellum tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of AFG3L2 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
AFG3L2 Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a protein localized in mitochondria and closely related to paraplegin. The paraplegin gene is responsible for an autosomal recessive form of hereditary spastic paraplegia. This gene is a candidate gene for other hereditary spastic paraplegias or neurodegenerative disorders.
REFERENCES
Edener, U., et al. Eur. J. Hum. Genet. 18(8):965-968(2010) Di Bella, D., et al. Nat. Genet. 42(4):313-321(2010) Augustin, S., et al. Mol. Cell 35(5):574-585(2009) Mariotti, C., et al. Cerebellum 7(2):184-188(2008) Cagnoli, C., et al. Brain 129 (PT 1), 235-242 (2006) :